| Management target | Revenue 45.0% FY27 |
|---|
| Revenue growth | 32% YoY Q2 revenue growth; ₹507 Cr for H1 FY27. |
|---|---|
| Margins | EBITDA margin moderated to 27% due to Rajasthan project ramp-up costs. |
| Demand visibility | Strong demand in under-served rural areas via statewide diagnostic networks. |
| Management confidence | Confident in PPP model despite receivable delays and margin moderation. |
Growth
Revenue grew 32% YoY in Q2, driven by Rajasthan PPP and retail segment (35% growth).
Outlook
Management expects ₹400 Cr cash-based revenue and double-digit retail contribution by FY27 end.
Risks
High receivables (₹472 Cr) from government contracts and upfront costs for new projects impact profitability.
Last quarter's promises, checked
Delivered
- Guided QoQ margin gain → EBITDA 25% (Q1) to 27% (Q2) (= BEAT)
Partly delivered
- Guided 10-15% retail share FY27 → Q1 ~9%, now 'double-digit' by FY27-end (= PARTIAL)
Missed
- Guided Rajasthan ₹200-250 Cr aspiration → cut to ₹100-150 Cr FY27 (= MISS)
- Guided Karnataka dues collected by Q2 → ₹472 Cr govt receivables still flagged (= MISS)
- Guided retail acceleration → growth slowed 64% (Q1) to 35% (Q2) (= MISS)
Earnings Call Transcript filed with NSE, NSE: KRSNAA. Summary written with AI assistance from the document.
Krsnaa Diagnostics Ltd: key numbers
- Share price
- ₹480.15
- Market cap
- ₹1,558 Cr
- Revenue (annual)
- ₹772.8 Cr
- Net profit (annual)
- ₹101.4 Cr
- P/E (TTM)
- 15.9×Sector 53.7×
- Promoter holding
- 27.11%+0.00% QoQ
- FII holding
- 3.84%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krsnaa Diagnostics Ltd
All →Krsnaa Diagnostics Bags New Order from Municipal Corporation of Delhi
Krsnaa Diagnostics secured a 15-year cash-based PPP project from the Municipal Corporation of Delhi. The contract involves establishing CT Scan and MRI facilities at three public hospitals.
- From
- Municipal Corporation of Delhi (MCD)
- Execution
- 15 years
- diagnostic facilities
- 3.0 project sites
Krsnaa Diagnostics Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 2,710 Mn (+32% YoY) and PAT INR 246 Mn (+3%). EBITDA margin fell to 27% from 29% on Rajasthan fixed costs.
Krsnaa Diagnostics Results Update
Krsnaa Diagnostics reported record Q2 revenue of Rs 2,710 million, up 32% year on year. H1 PAT fell to Rs 411 million on Rajasthan project costs.
Krsnaa Diagnostics Q2 FY27 Results: Net Profit ₹24.6 Cr, Up 2.9% YoY
Krsnaa Diagnostics Ltd reported revenue from operations of ₹271 Cr (+31.6% YoY) and net profit of ₹24.6 Cr (+2.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹24.6 Cr · +2.9% YoY
Krsnaa Diagnostics Board Meeting Date
Krsnaa Diagnostics intimated that its board will meet on November 2, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. No financial figures are disclosed in this notice.
Krsnaa Diagnostics Partnership
Krsnaa Diagnostics has formed a strategic AI collaboration with AZmed to integrate AI radiology solutions for enhanced operational efficiency and scalable diagnostic reporting.
- From
- AZmed